ArticleBMC cancer2022

NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.

Carolina Di Benedetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.